article thumbnail

STAT+: Lawmakers grill UnitedHealth CEO on Change cyberattack: ‘Your company let the country down’

STAT

Senators repeatedly interrupted Witty, trying to keep him to concrete answers and promises. Lawmakers on both sides of the aisle were exasperated with UnitedHealth.

article thumbnail

STAT+: Washington wants to avert another Change Healthcare-like fiasco. Here’s what could be coming

STAT

Washington is cracking down on the technology running behind the scenes in health care following a debilitating cyberattack on a health care payments processing company — and it could have major implications for hospitals and the vendors selling crucial IT.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

UnitedHealth’s Andrew Witty gets no pity in Congress

STAT

Witty gets no pity UnitedHealth CEO Andrew Witty was the target of both a Senate and House hearing yesterday, and he faced the full wrath and exasperation of lawmakers angry about the Change Healthcare cyberattack that disrupted payment processing across the country, my colleague Brittany Trang reports. Read the rest…

article thumbnail

A Guide to Card Payment Processors for Your Pharmacy

pharmacy mentor

In today’s fast-paced retail environment, seamless and efficient payment processing is crucial for any business, and pharmacies are no exception. Pharmacies that accept card payments can provide a smoother and faster checkout experience, leading to happier customers and potentially higher sales.

article thumbnail

Supply chain middlemen ‘pocket half of US branded medicine spending’

pharmaphorum

BRG – which says it aims to bring “clarity” to drug distribution and payment processes – said insurers, PBMs and government programmes received more than $141 billion in spending on brand medicines in 2020, up from $50 billion in 2013.

article thumbnail

Delayed payments to pharma MSMEs: A major challenge

Express Pharma

This proposal seeks to address the persistent issue of delayed payments faced by pharma MSMEs and offer them the necessary liquidity support they require. Encouraging the adoption of digital payment systems and e-invoicing can streamline payment processes and reduce paperwork.

article thumbnail

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

FDA Law Blog: Biosimilars

Point-of-Sale (POS) Discounts and Payment Processes: As under the CGDP, PDP sponsors will provide applicable discounts at the POS. CMS will provide this by January 2024 but will not extend the recalculation option to manufacturers that have not signed a Discount Program agreement.

Labelling 105